Inactive Instrument

Insiders Theravance Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 24	Innoviva, Inc.'s Subsidiary Innoviva Specialty Therapeutics, Inc.?s Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024	CI
Mar. 04	Armata Pharmaceuticals Secures $35 Million Credit Agreement From Innoviva Unit	MT

Innoviva, Inc. Appoints David Altarac as Chief Medical Officer of Innoviva Specialty Therapeutics	Feb. 06	CI
Innoviva Insider Sold Shares Worth $153,810, According to a Recent SEC Filing	Nov. 17	MT
Innoviva Names Stephen Basso as Finance Chief	23-08-28	MT
Innoviva, Inc. Appoints Stephen Basso as Chief Financial Officer	23-08-25	CI
Innoviva, Inc. Announces Resignation of Deborah L. Birx as Member of the Board of Directors and Chair of the Audit Committee	23-07-11	CI
Insider Buy: Innoviva	23-05-31	MT
Innoviva, Inc. Announces Retirement of George Bickerstaff, III, as Board Chairman	23-04-28	CI
Innoviva, Inc. Announces Appointment of Sapna Srivastava to the Board of Directors	23-01-04	CI
Insider Trends: Inova Technology Sees Insider Acquisition Interrupting 90-Days of Sells	21-05-25	MT
Insider Trends: Inova Technology Insider Prolongs 90-Day Selling Trend	21-05-24	MT
Innoviva, Inc. Announce Board Changes	21-04-05	CI
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Armata Pharmaceuticals Stock	21-03-17	MT
Innoviva, Inc. Appoints Deborah L. Birx to its Board of Directors	21-03-10	CI
Innoviva, Inc. Announces Executive Changes	20-05-21	CI
Innoviva, Inc. Announces Executive Terminations	18-10-01	CI
Innoviva, Inc. Announces Executive Changes	18-08-08	CI
Innoviva, Inc. Appoints Geoffrey Hulme as Interim Principal Executive Officer	18-05-22	CI
Innoviva, Inc. Announces Board Changes	18-03-23	CI
Innoviva, Inc. Announces Board Appointments	18-02-13	CI
Innoviva, Inc. Announces Executive Changes	18-02-07	CI

No results for this search